Rock Springs Capital Management LP's Net Worth
$1.67 Million
Who is Rock Springs Capital Management LP?
Rock Springs Capital Management LP has an estimated net worth of $1.67 Million. This is based on reported shares across multiple companies, which include Atea Pharmaceuticals, Inc., Nivalis Therapeutics, Inc., Theseus Pharmaceuticals, Inc., Verve Therapeutics, Inc., Xilio Therapeutics, Inc., Inozyme Pharma, Inc., Cerulean Pharma Inc., Tempest Therapeutics, Inc., Homology Medicines, Inc., and IMARA Inc..
SEC CIK
Rock Springs Capital Management LP's CIK is 0001595725
Past Insider Trading and Trends
2014 was Rock Springs Capital Management LP's most active year for acquiring shares with 1 total transactions. Rock Springs Capital Management LP's most active month to acquire stocks was the month of March. 2014 was Rock Springs Capital Management LP's most active year for disposing of shares, totalling 1 transactions. Rock Springs Capital Management LP's most active month to dispose stocks was the month of March. 2014 saw Rock Springs Capital Management LP paying a total of $0.00 for 464,365 shares, this is the most they've acquired in one year. In 2014 Rock Springs Capital Management LP cashed out on 464,365 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Atea Pharmaceuticals, Inc. (AVIR) Snapshot price: $3.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +114.75% | 1.94M |
$24.00 | $6,000,000.00 | 3.64M |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nivalis Therapeutics, Inc. (ALPN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 564.36K |
$14.00 |
—
| 564.36K |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +196.57% | 686.65K |
$16.00 | $4,000,000.00 | 1.04M |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.08M |
$19.00 |
—
| 1.08M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +186.10% | 1.41M |
$16.00 | $8,000,000.00 | 2.16M |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||